DIA 2020 Global Annual Meeting

This event is now offered in a new entirely virtual format.

Back to Agenda

Outcomes as a Pathway to Value and Pharma, Payer, Provider Collaboration

Session Chair(s)

Richard Gliklich, MD

Chief Executive Officer

OM1, United States

A focus on value is driving efforts to improve outcomes and reduce costs. This session explores the use of real world data to predict treatment benefit, response and cost and the use of measurable outcomes for supporting contracting and clinical decisions.

Learning Objective : Describe standardized outcomes measurement practices and initiatives and their importance to getting to a partnered solution; Discuss how predictive analytics are being applied to real-world data to measure and predict outcomes; Identify opportunities for using real world and outcomes data for supporting formulary, access, and clinical decision making.

Speaker(s)

Developing and Leveraging Harmonized Outcome Measures in Depression

Elise Berliner, PhD

Oracle Life Sciences, United States

Global Senior Principal for Real World Evidence Strategy

Patient-Reported Outcomes, Experience, Quality, and Value-Based Payment

Rachel Dupre Brodie

Pacific Business Group on Health, United States

Senior Director, Measurement and Accountability

Have an account?